Related Experiment Video

Updated: Aug 20, 2026

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
10:31

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

Published on: September 26, 2025

[Deciphering the action mechanism of hepcidin]

Gaël Nicolas, Sophie Vaulont

    Medecine Sciences : M/S
    |January 11, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
    05:55

    Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

    Published on: December 21, 2019

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    Related Experiment Videos

    Last Updated: Aug 20, 2026

    A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2
    10:31

    A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

    Published on: September 26, 2025

    Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
    05:55

    Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

    Published on: December 21, 2019

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
    11:34

    A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

    Published on: May 10, 2022

    Related Concept Videos

    Regulation of the Unfolded Protein Response01:31

    Regulation of the Unfolded Protein Response

    Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
    Export of Misfolded Proteins out of the ER01:32

    Export of Misfolded Proteins out of the ER

    After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

    Articles linked to this work by shared authors, journal, and citation graph.

    PLCG2 downregulation impairs synaptic function and increases Alzheimer's disease hallmarks in neuronal cultures.

    Nature genetics·2026

    APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.

    Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

    Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk.

    Annals of neurology·2026

    Eating behaviour phenotype in the MYT1L-related neurodevelopmental disorder: a deep phenotyping study using standardized questionnaires.

    Orphanet journal of rare diseases·2026

    Skin hepcidin overexpression is sufficient to promote systemic iron deficiency.

    Haematologica·2026

    Assessing the de novo paradigm in sporadic early-onset Alzheimer disease trios.

    Molecular psychiatry·2026

    [Serial cloners of Yamanashi].

    Medecine sciences : M/S·2026

    [Long COVID: between a syndromic framework and an etiological imperative].

    Medecine sciences : M/S·2026

    [The Edmonton transplantation protocol, 25 years later: toward remission of type 1 diabetes?]

    Medecine sciences : M/S·2026

    [Bioinformatics and omics analyses: chronology of a new scientific approach].

    Medecine sciences : M/S·2026

    [The 2025 Nobel Prize: regulatory T lymphocytes, the long-neglected "immunosuppressive cells". A brief history of a scientific renaissance and its emergence in France].

    Medecine sciences : M/S·2026

    [Contributions of seeding amplification assays to the diagnosis of synucleinopathies].

    Medecine sciences : M/S·2026

    Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

    Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

    Haematologica·2026

    Rare inherited coagulation disorders and thrombosis.

    Haematologica·2026

    Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

    Cureus·2026

    Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

    European journal of case reports in internal medicine·2026

    Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

    Frontiers in medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us